On Nov. 19, Health Canada announced the approval of the Pfizer-BioNTech two-dose COVID-19 vaccine for children between five and 11-years-old, allowing children in that age group...
Pfizer says it has submitted initial trial data for the use of its COVID-19 vaccine in children aged five to 11 to Health Canada. In an...